AGL 2043 is an effective inhibitor of PDGFR (IC50=0.8 µM) and TEL-PDGFR kinases, as well as FLT3 and KIT kinases. AGL 2043 can effectively inhibit porcine cardiac smooth muscle cell proliferation and balloon-induced vascular stenosis, and is suitable for development as an anti-restenotic and anticancer agent[1].
Molecular Weight:
280.35
CAS Number:
[226717-28-8]
Formula:
C15H12N4S
Target:
FLT3,PDGFR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
